Genentech

Genentech's Venetoclax Drug For Lymphocytic Leukemia

Medicine & Technology Aug 13, 2015

The pharmaceutical company Genentech announced that the Phase II study for Venetoclax has meet its primary endpoint.

Most Popular

Worst ‘Cannibal’ Solar Storm in 165 Years Expected to Crash Into Earth’s Atmosphere Tonight Causing GPS, Power Outages

Worst ‘Cannibal’ Solar Storm in 165 Years Expected to Crash Into Earth’s Atmosphere Tonight Causing GPS, Power Outages

Cave of Death in Costa Rica Appears Harmless But Can Instantly Kill Anyone at the Entrance

Cave of Death in Costa Rica Appears Harmless but Can Instantly Kill Anyone at the Entrance

Solar Storm Alert: Rare Cosmic Event,

Solar Storm Alert: Rare Cosmic Event, First in 20 Years, Threatens Earth's Tech

Kinetic Magnetism: Quantum Motion of Atom Gives Rise to a New Mechanism for Attraction and Repulsion

Kinetic Magnetism: Quantum Motion of Atom Gives Rise to New Mechanism for Attraction and Repulsion

NOAA’s RAP-Chem Atmospheric Chemistry Prediction System Reveals How Pollen Can Change the Weather

NOAA’s RAP-Chem Atmospheric Chemistry Prediction System Reveals How Pollen Can Change the Weather

Recommended Stories

Levitating Robot Train in the Moon

TECH & INNOVATION

NASA Advances Lunar Levitation Robot Train Concept for Moon Base by 2030s To Develop Science Fiction-Like Projects

Car-Sized Asteroid Made a Super Close Approach to Planet Earth in Near Miss Flyby

SPACE

Car-Sized Asteroid Made a Super Close Approach to Planet Earth in Near Miss Flyby

Massive X8.7 Solar Flare From Super-Active Sunspot Causes Radio Blackouts Over North and South America Days After Widespread Aurora Displays

SPACE

Massive X8.7 Solar Flare From Super-Active Sunspot Causes Radio Blackouts Over North, South America Days After Widespread Aurora Displays

North America Suffers Radio Blackout After a Big X-Flare on Tuesday

SPACE

North America Suffers Radio Blackout After a Big X-Flare on Tuesday